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MicroRNAs (miRNAs) are a class of small non-coding RNAs with important roles in various biological
and pathological processes, including osteoblast differentiation. Here, we identiﬁed miR-96 as a
positive regulator of osteogenic differentiation in a mouse osteoblastic cell line (MC3T3-E1) and
in mouse bone marrow-derived mesenchymal stem cells. Moreover, we found that miR-96 down-
regulates post-transcriptional expression of heparin-binding EGF-like growth factor (HB-EGF) by
speciﬁcally binding to the 30untranslated region of HB-EGF mRNA. Furthermore, in MC3T3-E1 cells,
miR-96-induced HB-EGF down-regulation suppressed the phosphorylation of epidermal growth fac-
tor receptor (EGFR) and of extracellular signal-regulated kinase 1 (ERK1) and AKT, which both lie
downstream of EGFR activation. Taken together, miR-96 promotes osteogenic differentiation by
inhibiting HB-EGF and by blocking the HB-EGF–EGFR signaling pathway in osteoblastic cells.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and MSCs by down-regulating Wnt signaling inhibitors SOST,MicroRNAs (miRNAs) are a class of small non-coding RNAswhich
mediate the inhibition of translation and/or mRNA degradation by
binding to the 30untranslated region (UTR) of their target mRNAs
[1]. miRNAs are generated from several hundred-nucleotide long
primary transcripts (pri-miRNAs) that are processed by the
enzymes Drosha and Dicer to 22-nucleotide mature miRNAs [2].
Emerging evidence has indicated that miRNAs play important roles
in development, homeostasis and diseases. They are involved in a
wide range of biological and pathological processes, including cell
differentiation, proliferation and apoptosis [3].
Dicer deﬁciency in chondrocytes, osteoblasts and osteoclasts
suggested essential roles of miRNAs in skeletal development and
bone homeostasis [4–6]. Several miRNAs have been shown to
regulate the osteogenic differentiation of mesenchymal stem
cells (MSCs) and osteoblasts. For example, miR-133 inhibits
BMP2-induced osteogenic differentiation of C2C12 cells by repress-
ing runt-related transcription factor 2 (Runx2) [7]. miR-143 and
miR-145 suppresses osteogenic differentiation of MC3T3-E1 cells
by targeting Osterix [8,9]. miR-214 negatively regulates osteogene-
sis of MC3T3-E1 cells and bone formation by inhibiting ATF4 [10].
miR-218 promotes commitment and differentiation of MC3T3-E1DKK2 and SFRP2 [11]. miR-146a inhibits osteogenic differentiation
by targeting JMJD3 in human mesenchymal stem cells [12]. How-
ever, miRNAs that regulate osteoblast differentiation and bone for-
mation still require further investigation.
Heparin-binding epidermal growth factor-like growth factor
(HBEGF), a member of the epidermal growth factor (EGF) family,
can bind to EGF receptor (EGFR) with high afﬁnity and activate
EGFR signaling, which includes extracellular signal-regulated
kinase (ERK), JNK and phosphatidylinositol 3-kinase (PI3K)/Akt
[13–16]. EGFR signaling is involved in numerous physiological
and pathological processes, including osteogenic differentiation
and bone formation. Osteoblast proliferation and differentiation
are abnormal in EGFR-deﬁcient mice, with impaired bone forma-
tion and skeleton structure [17,18]. HBEGF–EGFR signaling inhibits
osteogenic differentiation of MSCs, MC3T3-E1 and C2C12 cells
[15,16,19].
In this study, we focused on miR-96 that is signiﬁcantly upreg-
ulated during osteogenic differentiation of MSCs [20]. We found
that miR-96 level is positively correlated with bone formation as
well as osteoblast differentiation. Gain- and loss-of-function exper-
iments showed that miR-96 is a positive regulator of osteogenic
differentiation in MC3T3-E1 and bone marrow-derived mesenchy-
mal stem cells (BMSCs). Luciferase assay together with Western
blot assay indicated that HBEGF is a target of miR-96. Further,
miR-96-mediated promotion of osteogenic differentiation was
caused by inhibiting HBEGF and blocking HBEGF–EGFR signaling
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into the roles of miRNAs in osteoblast differentiation.
2. Materials and methods
2.1. Bioinformatics prediction
Three programs TargetScan (www.targetscan.org), miRanda
(www.microrna.org/microrna/home.do) and PicTar (pictar.mdc-
berlin.de) were used to carry out the predictive search for miR-
96 target.
2.2. Reagents
Agomir negative control (agomir-NC), agomir-96, antagomir
negative control (antagomir-NC), and antagomir-96, were pur-
chased from Shanghai GenePharma, China. These products, chem-
ically modiﬁed to enhanced their stability, are more suitable for
monitoring the miRNA gain- and loss-of-function studies in longer
period of time relative to miRNA mimics and inhibitors [10].
HBEGF siRNA (si-HBEGF) and negative control (si-NC) were pur-
chased from Santa Cruz Biotechnology, USA. Lipofectamine 2000
was purchased form Invitrogen, USA.
2.3. Animals
The female C57BL/6J mice were purchased from Third Military
Medical University (Chongqing, China) and underwent ovariec-
tomy (OVX) or sham operation at 8 week of age. At 16 week after
surgery (24 week of age), the mice were sacriﬁced and bilateral
femurs were dissected for microCT scanning (lCT 40-Scanco Med-
ical, Switzerland) and real-time PCR analysis. All the experimental
procedures were approved by the Animal Care and Use Committee
of Third Military Medical University.
2.4. Cell culture and osteogenic differentiation
MC3T3-E1 osteoprogenitors, which were purchased from
Shanghai Cell Bank of Chinese Academy of Sciences, were cultured
in a-MEM medium with 10% FBS (Gibco, USA), and 100 U/ml pen-
icillin and 100 lg/ml streptomycin (Gibco, USA) at 37 C with 5%
CO2. At 100% conﬂuence (day 0), cells were treated with osteogenic
differentiation medium containing 10 mM b-glycerophosphate and
50 lg/ml of ascorbic acid. The differentiation mediumwas changed
every other day for osteogenic differentiation induction.
BMSCs were isolated by ﬂushing bone marrow of femurs and
tibia of 6–8-week-old C57BL/6J mice (Third Military Medical Uni-
versity, China). They were cultured in DMEM medium with 20%
FBS, 100 U/ml penicillin and 100 lg/ml streptomycin at 37 C with
5% CO2. At 100% conﬂuence (day 0), differentiationmedium (DMEM
medium plus 20% FBS, 1% penicillin/streptomycin, 2 mM L-gluta-
mine, 3 mM b-glycerophosphate, 50 lg/ml of ascorbic acid) was
added and refreshedevery 2 days for osteogenic differentiation [11].
Primary osteoblasts were isolated from calvaria of newborn
C57BL/6J mice as described previously [21]. Cells collected from
the last two digests were expanded in 10-cm cell culture dish until
100% conﬂuence in a-MEM with 10% FBS, 2 mmol glutamine,
100 U/ml penicillin, and 100 lg/ml streptomycin. Then cells were
harvested for real-time PCR analysis.
2.5. Plasmid construction
Total RNA from MC3T3-E1 cells was reverse-transcribed into
cDNA by iScriptTM cDNA synthesis Kit (Bio-Rad, USA). A 791 bp
fragment of the HBEGF 30UTR containing miR-96 target site wasampliﬁed from the above cDNA using primers (forward
50CGGGGTACCCCGCCAGTTGCTACCCTGACTGG30; reverse 50CCCAA-
GCTTGGGAAACCGATCCCTGCACTCTG30) and inserted into pGL3-
basic vector by KpnI and HindIII to generate reporter vector
pGL3-Hbegf 30UTR WT. The mutated vector of HBEGF 30UTR
(pGL3-Hbegf 30UTR Mut) was ampliﬁed from reporter plasmid
template using primers (forward 50CAGAGCCTCTAACTCGGAAAC-
AGACCATGCCC30; reverse 50GGGCATGGTCTGTTTCCGAGTTAGAGG-
CTCTG30; the bold letters indicate mutations), as described
previously [22]. A 854 bp fragment for HBEGF open reading frame
(ORF) without 30UTR was ampliﬁed by PCR with the above cDNA
using primers (forward 50CCGGAATTCCGGCAGGATCTCACCCAG-
AGGCA30; reverse 50CCGCTCGAGCGGACGTGTAACGAACCACTGT-
CT30) and cloned into the expression vector pcDNA3.1 by EcoRI
and XhoI to generate HBEGF expression vector. All the cloned vec-
tors were veriﬁed by DNA sequencing (Shanghai Sangon, China).
2.6. Luciferase reporter assay
MC3T3-E1 cells were seeded in 12-well plate at 105 cells/well
1 day proceeding transfection and reached to 70–80% conﬂuence
at the time of transfection. 0.5 lg pGL3-HBEGF 30UTR WT or
mutated vector was cotransfected with 30 pmol agomir-NC, ago-
mir-96, antagomir-NC, or antagomir-96 into cells using Lipofect-
amine 2000 according to manufacturer’s instructions. Cells were
harvested in reporter lysis buffer 48 h after transfection. Relative
luciferase activities were determined by dual-luciferase reporter
assay system (Promega, USA).
2.7. RNA isolation and quantitative real-time PCR
Total RNA was isolated with miRNeasy Mini Kit (Qiagen, USA)
following the manufacturer’s protocol. For mRNA assay, cDNA syn-
thesis was performed using iScriptTM cDNA synthesis Kit (Bio-Rad,
USA) and quantiﬁcation of mRNA level was determined by SYBR
Green Master Mix (Applied Biosystem, USA) with primers synthe-
sized by Shanghai Invitrogen (Primers sequences are listed in
Table 1). The relative mRNA levels were normalized to b-actin
expression. For miRNA assay, cDNA synthesis and quantiﬁcation
of miRNAs were conducted by miScript reverse transcription kit
and miScript primer assay (Qiagen, USA). The relative miRNA levels
were normalized to RNU6 expression.
2.8. Western blot analysis
Cells were lysed in RIPA buffer with proteinase and phosphatase
inhibitors (Roche, USA). Equal amounts of cell lysates were loaded
in SDS–PAGE and then transferred to PVDF membranes, which
were then blocked with 5% BSA for 1 h, incubated with primary
antibodies (Santa Cruz, USA) for 2 h and secondary antibody (Santa
Cruz, USA) for 1 h. After three washes with TBST, chemilumine-
sence was detected by Bio-Rad ChemiDoc.
2.9. Alkaline phosphatase staining
Cells were rinsed with PBS solution and ﬁxed with 4% formalde-
hyde for 2 min at room temperature. After three washes with PBS,
cells were stained with BCIP/NBT solution (Abcam, USA) following
the manufacturer’s instructions. Alp positive cells were stained
blue/purple.
2.10. Statistical analysis
Data are showed as means ± S.D. Statistical analysis was per-
formed using Student’s t test. Differences were considered signiﬁ-
cant at P values of <0.05.
Table 1
Primers for real-time PCR analysis.
HBEGF Forward 50CAGAGTGCAGGGATCGGTTT30
Reverse 50CGGAACACGAACGGTAGACA30
ALP Forward 50CTACGCACCCTGTTCTGAGG30
Reverse 50GGAAGTTGCCTGGACCTCTC30
OCN Forward 50GCTTAACCCTGCTTGTGACG30
Reverse 50TTTGGCTTTAGGGCAGCACA30
b-Actin Forward 50CCACCATGTACCCAGGCATT30
Reverse 50CAGCTCAGTAACAGTCCGCC30
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3.1. miR-96 levels positively correlate with bone formation and
osteogenic differentiation
We ﬁrstly explored the relationship between miR-96 expres-
sion and bone formation at bone tissue level (femur). We found
that miR-96 level was signiﬁcantly reduced in OVX-induced osteo-
porosis mice with decreased bone mineral density (BMD) com-
pared with the control group (Fig. 1A), which suggested that
miR-96 expression is positively correlated with bone formation.
Then we determined that there is a higher miR-96 expression in
primary osteoblasts and MC3T3-E1 cells compared with BMSCs
(Fig. 1B). Further, miR-96 level was upregulated during osteogenic
differentiation of MC3T3-E1 cells (Fig. 1C) and BMSCs (Fig. 1D)Fig. 1. miR-96 levels positively correlate with bone formation and osteogenic differentiat
by real-time PCR in femurs of female mice with OVX or control mice. ⁄P < 0.05 versus co
cells. ⁄P < 0.05 versus BMSCs (n = 3). (C) Alp, Ocn mRNA and miR-96 levels during osteog
osteogenic differentiation in BMSCs.with osteogenic differentiation medium, which was accompanied
by upregulation of osteogenic markers alkaline phosphatase (Alp)
and osteocalcin (Ocn). These results indicated that there is a posi-
tive correlation between miR-96 expression and osteoblast
differentiation.
3.2. miR-96 promotes osteogenic differentiation of MC3T3-E1 cells and
BMSCs
We performed gain- and loss-of-function experiments to inves-
tigate the role of miR-96 in MC3T3-E1 cells differentiation. Intra-
cellular miR-96 levels were upregulated by agomir-96 treatment
and downregulated by antagomir-96 treatment (Fig. 2A). Com-
pared with negative control, agomir-96 increased while antago-
mir-96 decreased Alp mRNA levels after 3- or 7-day osteogenic
induction as well as Ocn mRNA levels after 7-day induction with
differentiation medium (Fig. 2B). In coincidence with changes in
mRNA levels, Alp activities were enhanced by agomir-96 while
weakened by antagomir-96, which was reﬂected by Alp staining
after 7-day osteogenic induction with differentiation medium
(Fig. 2C). We also addressed the role of miR-96 as an inducer of
osteogenic lineage commitment and progression using multipo-
tent BMSCs. Treatment with agomir-96 increased miR-96 level in
BMSCs (Fig. 2D). Upon induction with differentiation medium,
introduction of agomir-96 into BMSCs resulted in increased Alp
and Ocn mRNA levels throughout the time course (Fig. 2E). More-
over, Alp activities were continuously stronger in agomir-96 groupion. (A) Bone mineral density (BMD) quantiﬁed by lCT and miR-96 level determined
ntrol group (n = 6). (B) miR-96 levels in BMSCs, primary osteoblasts, and MC3T3-E1
enic differentiation in MC3T3-E1 cells. (D) Alp, Ocn mRNA and miR-96 levels during
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(Fig. 2F). Thus, miR-96 promotes osteogenic differentiation of
MC3T3-E1 cells and BMSCs.
3.3. miR-96 suppresses HBEGF–EGFR signaling by targeting HBEGF in
MC3T3-E1 cells
By bioinformatical programs, HBEGF was predicted to be a
potential target of miR-96. The potential miR-96 target siteFig. 2. miR-96 promotes osteogenic differentiation of MC3T3-E1 cells and BMSCs. (A) m
agomir-NC, agomir-96, antagomir-NC, or antagomir-96 into MC3T3-E1 cells seeded in 12
antagomir-NC, or antagomir-96 into MC3T3-E1 cells seeded in 12-well plates, cells w
expression was performed at day 3 and day 7. (C) 48 h after transfection (day 0) with 3
seeded in 12-well plates, cells were induced with differentiation medium. Alp staining wa
agomir-96 into BMSCs seeded in 12-well plates, cells were induced with differentiation m
28. (E) 48 h after transfection (day 0) with 30 pmol agomir-NC or agomir-96 into BMSCs
PCR for Alp and Ocn mRNA expression was performed at day 0, 7, 14, 21, and 28. (F) 48 h
in 12-well plates, cells were induced with differentiation medium. Alp staining was car
compared with antagomir-NC.(GUGCCAAA) is within the 30UTR of HBEGF mRNA at position
189–196 (Fig. 3A). The binding site sequence is highly conserved
across different species (Fig. 3B). We found that miR-96 suppressed
the luciferase activity of wildtype HBEGF 30UTR reporter, but this
suppression did not occur when binding site sequence was
mutated (Fig. 3C). These results indicated that HBEGF 30UTR is a
direct target of miR-96 in MC3T3-E1 cells. Moreover, HBEGF pro-
tein was downregulated by agomir-96 while upregulated by antag-
omir-96, but HBEGF mRNA level did not change in agomir-96- oriR-96 levels were quantiﬁed by real-time PCR 48 h after transfection with 30 pmol
-well plates. (B) 48 h after transfection (day 0) with 30 pmol agomir-NC, agomir-96,
ere induced with differentiation medium. Real-time PCR for Alp and Ocn mRNA
0 pmol agomir-NC, agomir-96, antagomir-NC, or antagomir-96 into MC3T3-E1 cells
s carried out at day 7. (D) 48 h after transfection (day 0) with 30 pmol agomir-NC or
edium. Real-time PCR for miR-96 expression was performed at day 0, 7, 14, 21, and
seeded in 12-well plates, cells were induced with differentiation medium. Real-time
after transfection (day 0) with 30 pmol agomir-NC or agomir-96 into BMSCs seeded
ried out at day 0, 7, 14, 21, and 28. ⁄P < 0.05, compared with agomir-NC; #P < 0.05,
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translation repression but not mRNA degradation of HBEGF in
MC3T3-E1 cells (Fig. 3D and E). Taken together, miR-96 negatively
regulates HBEGF expression by directly targeting 30UTR of HBEGF
mRNA. It is well-known that HBEGF–EGFR signaling plays impor-
tant roles in inhibiting osteogenic differentiation of MSCs and
MC3T3-E1 cells, thus, we further detected phosphorylation levels
of EGFR and its downstream molecules in agomir-96- or antago-
mir-96-transfected MC3T3-E1 cells by Western blot. As a result,
overexpression of miR-96 inhibited the phosphorylation but not
total levels of EGFR, ERK, and Akt. Conversely, the EGFR signaling
was activated by inhibition of miR-96. (Fig. 3F).
3.4. HBEGF knockdown by si-HBEGF promotes osteogenic
differentiation by blocking activation of EGFR signaling in MC3T3-E1
cells
We further determined whether HBEGF knockdown by siRNA
could result in the similar effects with miR-96. Transfection of
si-HBEGF reduced HBEGF expression in MC3T3-E1 cells (Fig. 4A).
Inhibition of HBEGF by siRNA signiﬁcantly stimulated osteogenic
differentiation reﬂected by the upregulation of Alp and Ocn mRNA
and the increase of Alp activity (Fig. 4B and C). Further, si-HBEGF
suppressed phosphorylation levels of EGFR, EKR, and Akt
(Fig. 4D), which was in consistent with miR-96. The similar effects
of si-HBEGF with those of miR-96 in MC3T3-E1 cells indicated thatFig. 3. miR-96 suppresses HBEGF-EGFR signaling by targeting HBEGF in MC3T3-E1 cells
mutated version. (B) Sequence alignment of the predicted binding site of miR-96 showed
HBEGF 30UTR were underlined. (C) 48 h after cotransfection of 0.5 lg reporter constru
agomir-NC, agomir-96, antagomir-NC, or antagomir-96 into MC3T3-E1 cells seeded in 12
luciferase activity was normalized to Renilla luciferase activity. (D) HBEGF mRNA lev
antagomir-96 into MC3T3-E1 cells seeded in 12-well plates. (E) Western blot for HBEGF p
NC, or antagomir-96 into MC3T3-E1 cells seeded in 6-well plates. (F) Western blot for p
60 pmol agomir-NC, agomir-96, antagomir-NC, or antagomir-96 into MC3T3-E1 cells semiR-96-induced osteogenic differentiation was via suppression of
HBEGF-EGFR signaling.
3.5. HBEGF inhibits miR-96-induced osteogenic differentiation in
MC3T3-E1 cells
To further conﬁrm that HBEGF is involved in miR-96-induced
osteoblast differentiation, we cotransfected agomir-NC or ago-
mir-96 with si-NC, si-HBEGF, empty vector (EV), or HBEGF expres-
sion vector into MC3T3-E1 cells, then performed real-time PCR for
Alp, Ocn mRNA levels and Alp staining for Alp activity. As a result,
knockdown of HBEGF by siRNA promoted miR-96-induced osteo-
genic differentiation in MC3T3-E1 cells, while overexpression of
HBEGF inhibited this induction (Fig. 5A, B, D and E). Overexpres-
sion of HBEGF by expression vector was conﬁrmed byWestern blot
(Fig. 5C). All these results further indicated that miR-96 mediates
the induction of osteogenic differentiation by targeting HBEGF.
4. Discussion
In recent years, increasing evidence has shown that miRNAs
play great roles in various biological and pathological processes,
including osteoblast differentiation and bone formation. Several
miRNAs have been identiﬁed as major regulators of osteoblast
differentiation and/or bone formation, and they can promote,
as well as suppress distinct osteogenic differentiation pathway. (A) Schematic diagram of miR-96 target site in the 30UTR of HBEGF mRNA and its
high conservation among different species. The sequences of miR-96 target site in
ct containing HBEGF wildtype (WT) 30UTR or Mutated (Mut) 30UTR with 30 pmol
-well plates, cells were harvested for dual-luciferase reporter assay. Relative ﬁreﬂy
els 48 h after transfection with 30 pmol agomir-NC, agomir-96, antagomir-NC, or
rotein levels 48 h after transfection with 60 pmol agomir-NC, agomir-96, antagomir-
-EGFR, EGFR, p-ERK, ERK, p-Akt, and Akt protein levels 48 h after transfection with
eded in 6-well plates. ⁄P < 0.05, compared with agomir-NC.
Fig. 4. HBEGF knockdown by si-HBEGF promotes osteogenic differentiation by blocking activation of EGFR signaling in MC3T3-E1 cells. (A) HBEGF protein level was
determined by Western blot 48 h after transfection with 60 pmol siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 6-well plates. (B) 48 h after transfection (day 0) with
30 pmol siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 12-well plates, cells were induced with differentiation medium. Real-time PCR for Alp and Ocn mRNA
expression was performed at day 3 and day 7. (C) 48 h after transfection (day 0) with 30 pmol siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 12-well plates, cells were
induced with osteogenic differentiation medium. Alp staining was carried out at day 7. (D) p-EGFR, EGFR, p-ERK, ERK, p-Akt, and Akt protein levels 48 h after transfection with
60 pmol siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 6-well plates. ⁄P < 0.05, compared with si-NC.
Fig. 5. HBEGF inhibits miR-96-induced osteogenic differentiation in MC3T3-E1 cells. (A) 48 h after cotransfection (day 0) of 30 pmol agomir-NC or agomir-96 with 30 pmol
siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 12-well plates, cells were induced with differentiation medium. Real-time PCR for Alp and Ocn mRNA expression was
performed at day 3 and day 7. ⁄P < 0.05, compared with agomir-NC + si-NC; #P < 0.05, compared with agomir-96 + si-NC. (B) 48 h after cotransfection (day 0) of 30 pmol
agomir-NC or agomir-96 with 30 pmol siRNA-NC or si-HBEGF into MC3T3-E1 cells seeded in 12-well plates, cells were induced with differentiation medium. Alp staining for
Alp activity was performed at day 7. (C) Western blot for HBEGF protein level 48 h after transfection with 1.0 lg empty vector (EV) or HBEGF expression vector into MC3T3-E1
cells seeded in 6-well plates. (D) 48 h after cotransfection (day 0) of 30 pmol agomir-NC or agomir-96 with 0.5 lg empty vector (EV) or HBEGF expression vector into
MC3T3-E1 cells seeded in 12-well plates, cells were induced with differentiation medium. Real-time PCR for Alp and Ocn mRNA expression was performed at day 3 and day 7.
⁄P < 0.05, compared with agomir-NC + EV; #P < 0.05, compared with agomir-96 + EV. (E) 48 h after cotransfection (day 0) of 30 pmol agomir-NC or agomir-96 with 0.5 lg
empty vector (EV) or HBEGF expression vector into MC3T3-E1 cells seeded in 12-well plates, cells were induced with differentiation medium. Alp staining was carried out at
day 7.
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of osteogenic differentiation by suppressing HBEGF-EGFR signaling
pathway.
miR-96 has been reported to be a positive regulator of cancer
growth, motility, and invasion. For example, miR-96 suppresses
HBP-1 to activate Wnt/b-catenin pathway, which contributes to
the proliferation of glioma cells [27]. miR-96 targets RECK to pro-
mote the growth and mobility of non-small cell lung cancer cells
as well as proliferation and invasion of breast cancer [28,29].
miR-96 plays an anti-apoptotic role in prostate cancer by inhibi-
tion of FOXO1 [30]. Moreover, miR-96 is highly expressed and
plays important roles in sensory tissues including inner ear
[31,32], retina and olfactory epithelia [33]. For instance, miR-96
regulates the progression of the physiological and morphological
differentiation of cochlear hair cells and mutations in miR-96 are
associated with non-syndromic progressive hearing loss in humans
and mice [34–36]. Nevertheless, the effect of miR-96 on osteogenic
differentiation and bone formation remains poorly understood. A
previous study showed that miR-96 expression was increased dur-
ing osteogenesis and adipogenesis, however, whether miR-96 can
regulate osteoblast differentiation and the mechanisms under that
are still unknown [20]. Here, we found that miR-96 expression pos-
itively correlates with bone formation and osteogenic differentia-
tion. We further identiﬁed miR-96 as a positive regulator of
osteogenic differentiation in MC3T3-E1 and BMSCs by gain- and
loss-of function study.
To address the molecular mechanisms involved in miR-96-
mediated osteogenesis, bioinformatical analysis combined with
dual-luciferase reporter assay was performed. Finally, HBEGF,
which is a member of EGF family, was identiﬁed as a target of
miR-96. The signaling network of EGF-like ligands and their
receptors regulates key processes of cell biology, such as prolifera-
tion, differentiation, survival, migration, and tumorigenesis.
Especially, EGF-like ligands, including EGF, HBEGF, amphiregulin,
TGFa, betacellulin, and epiregulin, strongly inhibit osteoblast dif-
ferentiation and mineralization in several lines of osteoblastic cells
[16,19,37], which accounts for miR-96-induced upregulation of
Alp, and Ocn and increase in Alp activity. In a previous study,
miR-1192 directly targets HBEGF through inhibition of translation
to exert stimulative effect on Runx2-induced osteogenic differenti-
ation of C2C12 cells [16], which is similar to our results about miR-
96.
Binding of HBEGF to EGFR can trigger receptor dimerization and
activate downstream kinases, including ERK, JNK, and PI3K/Akt, to
inhibit osteoblast differentiation [16,19,38]. Thus, we further
detected the phosphorylation of EGFR, ERK, and Akt in agomir-
96-treated MC3T3-E1 cells. Accompanied by downregulation of
HBEGF, phosphorylation of EGFR, ERK, and Akt was also reduced,
suggesting that miR-96-mediated HBEGF suppression stimulates
osteogenic differentiation using EGFR signaling. In addition, knock-
down of HBEGF by siRNA had similar effects with miR-96 on EGFR
signaling and osteoblast differentiation. Through these ﬁndings,
we addressed the molecular mechanism by which miR-96 pro-
motes osteogenic differentiation. That is, miR-96-induced osteo-
genic differentiation is mediated by blocking HBEGF-EGFR
signaling pathway.
In conclusion, the present study demonstrated that miR-96 acts
as a positive regulator of osteogenic differentiation by inhibiting
HBEGF, shedding new light on the roles of miRNAs in osteoblast
differentiation. The miR-96-HBEGF-EGFR pathway may be a novel
target for treatment of osseous defects.Conﬂict of interest
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